<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="http://onlinelibrarystatic.wiley.com/xslt/wol-journal-rss.xsl"
            type="text/xsl"?><rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"><channel rdf:about="http://onlinelibrary.wiley.com/rss/journal/10.1111/(ISSN)1600-0560" xmlns="http://purl.org/rss/1.0/"><title>Journal of Cutaneous Pathology</title><description> Wiley Online Library : Journal of Cutaneous Pathology</description><link>http://dx.doi.org/10.1111%2F%28ISSN%291600-0560</link><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc</dc:publisher><dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">en</dc:language><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">© 2012 John Wiley &amp; Sons A/S</dc:rights><prism:issn xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">0303-6987</prism:issn><prism:eIssn xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1600-0560</prism:eIssn><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">February 2012</prism:coverDisplayDate><prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">39</prism:volume><prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2</prism:number><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">219</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">309</prism:endingPage><image rdf:resource="http://onlinelibrary.wiley.com/store/10.1111/cup.2012.39.issue-2/asset/cover.gif?v=1&amp;s=f1a0d30be5ff3c16bff56e01ddb9bb7e5020f899"/><items><rdf:Seq><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01888.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01883.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01876.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01880.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01873.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01866.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01872.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01835.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01819.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01816.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01815.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01833.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01829.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01855.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01854.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01838.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01836.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01832.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01823.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01813.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01810.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01806.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01792.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01782.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01691.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2008.01181.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2008.01204.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01865_1.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01865_2.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01864.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01825.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01843.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01834.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01844.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01812.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01817.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01814.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01807.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01799.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01795.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01811.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01827.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01818.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01826.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01828.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01839.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01840.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01875.x"/></rdf:Seq></items></channel><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01888.x" xmlns="http://purl.org/rss/1.0/"><title>TRICHILEMMOMAS SHOW LOSS OF PTEN IN COWDEN SYNDROME BUT ONLY RARELY IN SPORADIC TUMORS</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01888.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">TRICHILEMMOMAS SHOW LOSS OF PTEN IN COWDEN SYNDROME BUT ONLY RARELY IN SPORADIC TUMORS</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Tariq Al-Zaid</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jeremy S. Ditelberg</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Victor G. Prieto</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Dina Lev</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Raja Luthra</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Michael A. Davies</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. Hafeez Diwan</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Wei-Lien Wang</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Alexander J. Lazar</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-07T08:44:37.916939-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2012.01888.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2012.01888.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01888.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Background: Trichilemmoma (TL) can occur as a solitary sporadic lesion usually on the face or as multiple facial lesions almost invariably associated with Cowden syndrome (CS). CS is a multisystem disorder caused by a germline inactivating mutation in PTEN (10q23.31), a tumor suppressor gene. We sought to identify PTEN loss by immunohistochemistry (IHC) in sporadic and CS-associated TL to determine whether IHC is a useful tool to assess an individual for CS.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Methods: 6 TL biopsies associated with CS and 33 biopsies without CS were retrieved. IHC for PTEN was performed. Results were scored as positive (reactivity in TL cells) or negative (no reactivity in TL cells); normal squamous epithelium and vascular endothelium served as internal positive controls.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Results: Complete PTEN loss was noted in 5/6 (83%) CS-associated TL and 1/33 (3%) sporadic (non-CS) TL.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Conclusion: Demonstration of complete PTEN loss in TL by IHC is strongly suggestive of association with CS, but retention of PTEN staining does not entirely exclude CS. Therefore, PTEN IHC in trichilemmomas may be helpful in screening TL for association with CS, but should be used in context with other established clinical criteria, and possibly germline PTEN genotyping to confirm a diagnosis of CS.</p></div>]]></content:encoded><description>Background: Trichilemmoma (TL) can occur as a solitary sporadic lesion usually on the face or as multiple facial lesions almost invariably associated with Cowden syndrome (CS). CS is a multisystem disorder caused by a germline inactivating mutation in PTEN (10q23.31), a tumor suppressor gene. We sought to identify PTEN loss by immunohistochemistry (IHC) in sporadic and CS-associated TL to determine whether IHC is a useful tool to assess an individual for CS.Methods: 6 TL biopsies associated with CS and 33 biopsies without CS were retrieved. IHC for PTEN was performed. Results were scored as positive (reactivity in TL cells) or negative (no reactivity in TL cells); normal squamous epithelium and vascular endothelium served as internal positive controls.Results: Complete PTEN loss was noted in 5/6 (83%) CS-associated TL and 1/33 (3%) sporadic (non-CS) TL.Conclusion: Demonstration of complete PTEN loss in TL by IHC is strongly suggestive of association with CS, but retention of PTEN staining does not entirely exclude CS. Therefore, PTEN IHC in trichilemmomas may be helpful in screening TL for association with CS, but should be used in context with other established clinical criteria, and possibly germline PTEN genotyping to confirm a diagnosis of CS.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01883.x" xmlns="http://purl.org/rss/1.0/"><title>Increased Twist expression in advanced stage of Mycosis fungoides and Sézary syndrome</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01883.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Increased Twist expression in advanced stage of Mycosis fungoides and Sézary syndrome</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Meghali Goswami</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Madeleine Duvic</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Alexis Dougherty</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Xiao Ni</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-03T13:09:47.266325-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2012.01883.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2012.01883.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01883.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Background:</b> The mechanisms of tumor progression in mycosis fungoides (MF) and Sézary syndrome (SS) are poorly understood. Twist, a transcription factor, is thought to promote solid tumor progression by blocking p53 and inhibiting c-myc-induced apoptosis. Whether Twist expression is correlated to MF/SS stages remains unknown.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods:</b> Twist, c-myc and p53 proteins in 68 MF/SS lesions across all T stages were examined by immunohistochemistry, and mRNA levels in peripheral blood CD4+ T-cells from SS patients were measured by QT-PCR.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results:</b> Positive staining for Twist was found in 12.5% (2/16) of T1 and 33.3% (7/21) of T2 early stage patches/plaques compared to 50.0% (9/18) of T3 tumors and 84.6% (11/13) of T4 erythroderma. Most T4 erythroderma were positive for Twist in dermal lymphocytes, with the strongest staining. Positive staining for c-myc was higher in T3/T4 lesions (29/31, 93.5%) than T1/T2 lesions (25/37, 67.6%, p&lt;0.05), with strongest staining in T3 tumors. Aberrant p53 expression was more common in T3/T4 lesions (8/31; 25.8%) than in T1/T2 lesions (2/37, 5.4%, p&lt;0.05). Twist mRNA was detected in all CD4+ T cells from SS patients but not in normal donors.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions:</b> Increased Twist protein expression in advanced MF/SS lesions suggests that Twist expression may correlate with MF/SS stages.</p></div>]]></content:encoded><description>Background: The mechanisms of tumor progression in mycosis fungoides (MF) and Sézary syndrome (SS) are poorly understood. Twist, a transcription factor, is thought to promote solid tumor progression by blocking p53 and inhibiting c-myc-induced apoptosis. Whether Twist expression is correlated to MF/SS stages remains unknown.Methods: Twist, c-myc and p53 proteins in 68 MF/SS lesions across all T stages were examined by immunohistochemistry, and mRNA levels in peripheral blood CD4+ T-cells from SS patients were measured by QT-PCR.Results: Positive staining for Twist was found in 12.5% (2/16) of T1 and 33.3% (7/21) of T2 early stage patches/plaques compared to 50.0% (9/18) of T3 tumors and 84.6% (11/13) of T4 erythroderma. Most T4 erythroderma were positive for Twist in dermal lymphocytes, with the strongest staining. Positive staining for c-myc was higher in T3/T4 lesions (29/31, 93.5%) than T1/T2 lesions (25/37, 67.6%, p&lt;0.05), with strongest staining in T3 tumors. Aberrant p53 expression was more common in T3/T4 lesions (8/31; 25.8%) than in T1/T2 lesions (2/37, 5.4%, p&lt;0.05). Twist mRNA was detected in all CD4+ T cells from SS patients but not in normal donors.Conclusions: Increased Twist protein expression in advanced MF/SS lesions suggests that Twist expression may correlate with MF/SS stages.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01876.x" xmlns="http://purl.org/rss/1.0/"><title>Desmoplastic trichoepithelioma with perineural involvement: a series of seven cases.</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01876.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Desmoplastic trichoepithelioma with perineural involvement: a series of seven cases.</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jaroslaw Jedrych</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">David Leffell</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jennifer M. McNiff</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-27T07:10:44.885738-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2012.01876.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2012.01876.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01876.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Desmoplastic trichoepithelioma is a benign follicular tumor occurring most commonly within facial skin of young and middle aged women, morphologically characterized by a superficial dermal proliferation of basaloid cells growing in narrow strands embedded in a desmoplastic stroma with associated small keratinizing cysts. Desmoplastic trichoepithelioma must be distinguished from other benign epithelial proliferations such as syringoma, microcystic adnexal carcinoma, and infiltrating basal cell carcinoma. Among morphological features useful in that distinction, perineural involvement is considered a feature indicative of malignancy. We present a series of seven desmoplastic trichoepitheliomas with otherwise typical presentation and morphology, nevertheless demonstrating epithelium present in the perineural spaces of adjacent small dermal nerves. Patients ranged in age from 14 to 66 years (mean 44 years). All seven tumors were restricted to dermis, showed strands of basaloid epithelium in desmoplastic stroma, and contained CK20-positive cells. Additionally, five of five examined tumors displayed diffuse expression of p75 neurotrophin receptor. Five patients were followed-up clinically (follow-up time range: 2 months - 4 years). No tumor recurrence was observed in any of these patients. We postulate that perineural involvement is an unusual feature of desmoplastic trichoepithelioma that should not be equated with malignancy or lead to unnecessary over-treatment.</p></div>]]></content:encoded><description>Desmoplastic trichoepithelioma is a benign follicular tumor occurring most commonly within facial skin of young and middle aged women, morphologically characterized by a superficial dermal proliferation of basaloid cells growing in narrow strands embedded in a desmoplastic stroma with associated small keratinizing cysts. Desmoplastic trichoepithelioma must be distinguished from other benign epithelial proliferations such as syringoma, microcystic adnexal carcinoma, and infiltrating basal cell carcinoma. Among morphological features useful in that distinction, perineural involvement is considered a feature indicative of malignancy. We present a series of seven desmoplastic trichoepitheliomas with otherwise typical presentation and morphology, nevertheless demonstrating epithelium present in the perineural spaces of adjacent small dermal nerves. Patients ranged in age from 14 to 66 years (mean 44 years). All seven tumors were restricted to dermis, showed strands of basaloid epithelium in desmoplastic stroma, and contained CK20-positive cells. Additionally, five of five examined tumors displayed diffuse expression of p75 neurotrophin receptor. Five patients were followed-up clinically (follow-up time range: 2 months - 4 years). No tumor recurrence was observed in any of these patients. We postulate that perineural involvement is an unusual feature of desmoplastic trichoepithelioma that should not be equated with malignancy or lead to unnecessary over-treatment.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01880.x" xmlns="http://purl.org/rss/1.0/"><title>Annular Hypopigmented Mycosis Fungoides: A Novel Ringed Variant</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01880.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Annular Hypopigmented Mycosis Fungoides: A Novel Ringed Variant</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Elizabeth E. Uhlenhake</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Darius M. Mehregan</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-24T11:22:36.539075-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2012.01880.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2012.01880.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01880.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Hypopigmented mycosis fungoides is a relatively uncommon variant of cutaneous lymphoma that is mostly seen in darker skin types. We present a novel and unique clinical presentation in an African-American female patient, consisting of regular hypopigmented annular rings in areas of normal skin and in more typical hypopigmented patches of mycosis fungoides. The lesions appeared diffusely on all extremities, anterior chest, and back. Histopathologic examination showed an atypical lymphocytic infiltrate at the dermal-epidermal junction with epidermotropism and few Pautrier's collections. The patient was otherwise healthy and improved with narrowband ultraviolet (UV)-B. This case represents a presentation of a most unusual variant of hypopigmented mycosis fungoides, for which we propose the name “annular hypopigmented mycosis fungoides.”</p></div>]]></content:encoded><description>Hypopigmented mycosis fungoides is a relatively uncommon variant of cutaneous lymphoma that is mostly seen in darker skin types. We present a novel and unique clinical presentation in an African-American female patient, consisting of regular hypopigmented annular rings in areas of normal skin and in more typical hypopigmented patches of mycosis fungoides. The lesions appeared diffusely on all extremities, anterior chest, and back. Histopathologic examination showed an atypical lymphocytic infiltrate at the dermal-epidermal junction with epidermotropism and few Pautrier's collections. The patient was otherwise healthy and improved with narrowband ultraviolet (UV)-B. This case represents a presentation of a most unusual variant of hypopigmented mycosis fungoides, for which we propose the name “annular hypopigmented mycosis fungoides.”</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01873.x" xmlns="http://purl.org/rss/1.0/"><title>Langerhans cell sarcoma in a patient with hairy cell leukemia: common clonal origin indicated by identical immunoglobulin gene rearrangements.</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01873.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Langerhans cell sarcoma in a patient with hairy cell leukemia: common clonal origin indicated by identical immunoglobulin gene rearrangements.</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Paul S. Furmanczyk</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Allison E. Lisle</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Russell B. Caldwell</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kenneth G. Kraemer</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Stephen E. Mercer</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Evan George</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Zsolt B. Argenyi</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-10T13:52:57.555602-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2012.01873.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2012.01873.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01873.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01866.x" xmlns="http://purl.org/rss/1.0/"><title>Psoriasiform pemphigus foliaceus: a report of two cases.</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01866.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Psoriasiform pemphigus foliaceus: a report of two cases.</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">SJ Grekin</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">MC Fox</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">JE Gudjonsson</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">DR Fullen</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-10T13:51:54.303536-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2012.01866.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2012.01866.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01866.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Pemphigus foliaceus (PF) represents an autoimmune blistering disease characterized by the disruption of epidermal intercellular adhesion proteins. Clinical findings include superficial crusted erosions in a seborrheic distribution, however the disease can rarely present as an exfoliative erythroderma. Histopathologic findings include acantholysis with cleavage within the granular layer. Direct immunofluorescence studies demonstrate intercellular IgG and complement deposition. We present two patients with a previous diagnosis of psoriasis who presented to our dermatology department with an exfoliative erythroderma, which ultimately proved to be due to PF based on histopathological features, direct immunofluorescence results, and levels of antibodies against desmoglein 1. Both patients responded well to oral prednisone and rituximab. This variant of PF should be entertained in both the clinical differential diagnosis of psoriasiform erythroderma and in the microscopic differential diagnosis of psoriasiform epidermal hyperplasia with focal acantholysis, particularly in patients for whom the clinical history is not classic for psoriasis or for whom conventional psoriasis therapies have not proven beneficial.</p></div>]]></content:encoded><description>Pemphigus foliaceus (PF) represents an autoimmune blistering disease characterized by the disruption of epidermal intercellular adhesion proteins. Clinical findings include superficial crusted erosions in a seborrheic distribution, however the disease can rarely present as an exfoliative erythroderma. Histopathologic findings include acantholysis with cleavage within the granular layer. Direct immunofluorescence studies demonstrate intercellular IgG and complement deposition. We present two patients with a previous diagnosis of psoriasis who presented to our dermatology department with an exfoliative erythroderma, which ultimately proved to be due to PF based on histopathological features, direct immunofluorescence results, and levels of antibodies against desmoglein 1. Both patients responded well to oral prednisone and rituximab. This variant of PF should be entertained in both the clinical differential diagnosis of psoriasiform erythroderma and in the microscopic differential diagnosis of psoriasiform epidermal hyperplasia with focal acantholysis, particularly in patients for whom the clinical history is not classic for psoriasis or for whom conventional psoriasis therapies have not proven beneficial.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01872.x" xmlns="http://purl.org/rss/1.0/"><title>Use of an expanded immunohistochemical panel to distinguish cutaneous Hodgkin lymphoma from histopathologic imitators</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01872.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Use of an expanded immunohistochemical panel to distinguish cutaneous Hodgkin lymphoma from histopathologic imitators</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Raymond J. Cho</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Timothy H. McCalmont</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Weiyun Z. Ai</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lindy P. Fox</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Patrick Treseler</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Laura B. Pincus</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-10T13:52:12.895045-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2012.01872.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2012.01872.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01872.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>In lymph nodes, classical Hodgkin lymphoma can typically be distinguished from non-Hodgkin lymphoma (NHL) by the presence of Hodgkin and Reed-Sternberg cells that co-express CD30 and CD15. However, anaplastic large cell lymphoma (ALCL) and diffuse large B-cell lymphoma (DLBCL) can show identical features, and some cases of classical Hodgkin lymphoma lack CD15 expression, rendering them difficult to differentiate from CD30-positive NHL. The differential diagnosis of cutaneous Hodgkin lymphoma similarly includes ALCL and DLBCL, and, additionally, tumors of mycosis fungoides. Recent studies have shown that classical Hodgkin lymphoma is of B-cell origin in virtually all cases, and shows at least focal weak expression of the B-cell marker PAX5 and often focal weak expression and no expression of the B-cell markers Oct-2 and BOB.1, respectively. All three of these markers are almost invariably absent in T-cell lymphomas and are strongly expressed in B-cell lymphomas. We report a 40-year-old man with classical Hodgkin lymphoma who developed cutaneous nodules. A biopsy from one revealed Hodgkin/Reed-Sternberg cells with a similar immunophenotype to the diagnostic lymph node biopsy, namely CD30+/CD15+, diffusely but weakly PAX5+, focally weakly Oct-2+ and lacking BOB.1 expression, thereby confirming a diagnosis of cutaneous Hodgkin lymphoma. To our knowledge, this is the first report of the expression pattern of the combination of PAX5, Oct-2 and BOB.1 in the context of cutaneous involvement by Hodgkin lymphoma.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Cho RJ, McCalmont TH, Ai WZ, Fox LP, Treseler P, Pincus LB. Case report demonstrating use of an expanded immunohistochemical panel to distinguish cutaneous Hodgkin lymphoma from histopathologic imitators.</p></div>]]></content:encoded><description>In lymph nodes, classical Hodgkin lymphoma can typically be distinguished from non-Hodgkin lymphoma (NHL) by the presence of Hodgkin and Reed-Sternberg cells that co-express CD30 and CD15. However, anaplastic large cell lymphoma (ALCL) and diffuse large B-cell lymphoma (DLBCL) can show identical features, and some cases of classical Hodgkin lymphoma lack CD15 expression, rendering them difficult to differentiate from CD30-positive NHL. The differential diagnosis of cutaneous Hodgkin lymphoma similarly includes ALCL and DLBCL, and, additionally, tumors of mycosis fungoides. Recent studies have shown that classical Hodgkin lymphoma is of B-cell origin in virtually all cases, and shows at least focal weak expression of the B-cell marker PAX5 and often focal weak expression and no expression of the B-cell markers Oct-2 and BOB.1, respectively. All three of these markers are almost invariably absent in T-cell lymphomas and are strongly expressed in B-cell lymphomas. We report a 40-year-old man with classical Hodgkin lymphoma who developed cutaneous nodules. A biopsy from one revealed Hodgkin/Reed-Sternberg cells with a similar immunophenotype to the diagnostic lymph node biopsy, namely CD30+/CD15+, diffusely but weakly PAX5+, focally weakly Oct-2+ and lacking BOB.1 expression, thereby confirming a diagnosis of cutaneous Hodgkin lymphoma. To our knowledge, this is the first report of the expression pattern of the combination of PAX5, Oct-2 and BOB.1 in the context of cutaneous involvement by Hodgkin lymphoma.Cho RJ, McCalmont TH, Ai WZ, Fox LP, Treseler P, Pincus LB. Case report demonstrating use of an expanded immunohistochemical panel to distinguish cutaneous Hodgkin lymphoma from histopathologic imitators.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01835.x" xmlns="http://purl.org/rss/1.0/"><title>Proteomic analysis of formalin-fixed, paraffin-embedded melanoma</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01835.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Proteomic analysis of formalin-fixed, paraffin-embedded melanoma</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Michael J. Murphy</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Karim Rezaul</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Amanda Phelps</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">David K. Han</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-11T06:35:59.98777-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01835.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01835.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01835.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01819.x" xmlns="http://purl.org/rss/1.0/"><title>What is the cause of retraction spaces associated with basal cell carcinoma?</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01819.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">What is the cause of retraction spaces associated with basal cell carcinoma?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Juan J. Ríos-Martín</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">David Moreno-Ramírez</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ricardo González-Cámpora</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-11T06:31:04.897199-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01819.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01819.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01819.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01816.x" xmlns="http://purl.org/rss/1.0/"><title>Molecular diagnostics in dermatology and dermatopathology - Edited by M. J. Murphy</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01816.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Molecular diagnostics in dermatology and dermatopathology - Edited by M. J. Murphy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Walter Burgdorf</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-11T06:30:59.970795-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01816.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01816.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01816.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01815.x" xmlns="http://purl.org/rss/1.0/"><title>An interstitial granulomatous pattern in localized lichen myxedematosus with associated monoclonal gammopathy</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01815.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">An interstitial granulomatous pattern in localized lichen myxedematosus with associated monoclonal gammopathy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Joanna G. Bolton</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Elizabeth K. Satter</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-11T06:30:52.687952-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01815.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01815.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01815.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01833.x" xmlns="http://purl.org/rss/1.0/"><title>Acute New World cutaneous leishmaniasis presenting as tuberculoid granulomatous dermatitis</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01833.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Acute New World cutaneous leishmaniasis presenting as tuberculoid granulomatous dermatitis</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Daniel D. Miller</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Barbara A. Gilchrest</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Amit Garg</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lynne J. Goldberg</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jag Bhawan</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-11T06:25:42.310067-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01833.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01833.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01833.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Acute primary cutaneous leishmaniasis typically presents microscopically with a lymphohistiocytic infiltrate containing admixed plasma cells, parasitized macrophages and abundant organisms. Tuberculoid granulomatous changes may occur in the later phases of primary infection. A 23-year-old male presented 1 month after visiting Peru with classic clinical findings of acute primary cutaneous leishmaniasis, while histopathology showed a tuberculoid granulomatous process that lacked any organisms in hematoxylin–eosin and fungal stains. Polymerase chain reaction (PCR) analysis and tissue cultures confirmed the diagnosis of cutaneous leishmaniasis with <em>Leishmania (Viannia) panamensis</em> infection. A pauci-organism tuberculoid granulomatous process may uncommonly be the presenting histopathology in the acute infectious phase of cutaneous leishmaniasis. Clinicians and dermatopathologists should be aware of this atypical presentation, which may cause diagnostic confusion and delay proper treatment. PCR testing should be employed in cases with high clinical suspicion when histopathology is not definitive.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Miller DD, Gilchrest BA, Garg A, Goldberg LJ, Bhawan J. Acute New World cutaneous leishmaniasis presenting as tuberculoid granulomatous dermatitis.</p></div>]]></content:encoded><description>Acute primary cutaneous leishmaniasis typically presents microscopically with a lymphohistiocytic infiltrate containing admixed plasma cells, parasitized macrophages and abundant organisms. Tuberculoid granulomatous changes may occur in the later phases of primary infection. A 23-year-old male presented 1 month after visiting Peru with classic clinical findings of acute primary cutaneous leishmaniasis, while histopathology showed a tuberculoid granulomatous process that lacked any organisms in hematoxylin–eosin and fungal stains. Polymerase chain reaction (PCR) analysis and tissue cultures confirmed the diagnosis of cutaneous leishmaniasis with Leishmania (Viannia) panamensis infection. A pauci-organism tuberculoid granulomatous process may uncommonly be the presenting histopathology in the acute infectious phase of cutaneous leishmaniasis. Clinicians and dermatopathologists should be aware of this atypical presentation, which may cause diagnostic confusion and delay proper treatment. PCR testing should be employed in cases with high clinical suspicion when histopathology is not definitive.Miller DD, Gilchrest BA, Garg A, Goldberg LJ, Bhawan J. Acute New World cutaneous leishmaniasis presenting as tuberculoid granulomatous dermatitis.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01829.x" xmlns="http://purl.org/rss/1.0/"><title>Azathioprine-induced EBV-positive mucocutaneous ulcer</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01829.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Azathioprine-induced EBV-positive mucocutaneous ulcer</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jamie L. McGinness</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kerith E. Spicknall</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Diya F. Mutasim</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-11T06:25:38.284818-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01829.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01829.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01829.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Epstein-Barr virus (EBV)-positive mucocutaneous ulcer was recently described as a clinicopathologic entity occurring secondary to iatrogenic or age-related immune suppression. The histopathology of EBV-positive mucocutaneous ulcer reveals a polymorphous infiltrate including atypical large B-cells and Reed-Sternberg-like cells which are CD20-positive, CD30-positive and EBV-positive. The disorder follows an indolent and self-limited course. We report a case of EBV-positive mucocutaneous ulcer secondary to prolonged use of azathioprine for the treatment of pemphigoid and highlight the need for recognition of this disorder by dermatopathologists and dermatologists.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>McGinness JL, Spicknall KE, Mutasim DF. Azathioprine-induced EBV-positive mucocutaneous ulcer.</p></div>]]></content:encoded><description>Epstein-Barr virus (EBV)-positive mucocutaneous ulcer was recently described as a clinicopathologic entity occurring secondary to iatrogenic or age-related immune suppression. The histopathology of EBV-positive mucocutaneous ulcer reveals a polymorphous infiltrate including atypical large B-cells and Reed-Sternberg-like cells which are CD20-positive, CD30-positive and EBV-positive. The disorder follows an indolent and self-limited course. We report a case of EBV-positive mucocutaneous ulcer secondary to prolonged use of azathioprine for the treatment of pemphigoid and highlight the need for recognition of this disorder by dermatopathologists and dermatologists.McGinness JL, Spicknall KE, Mutasim DF. Azathioprine-induced EBV-positive mucocutaneous ulcer.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01855.x" xmlns="http://purl.org/rss/1.0/"><title>Osteochondrolipoma: a subcutaneous lipoma with chondroid and bone differentiation of the chest wall</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01855.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Osteochondrolipoma: a subcutaneous lipoma with chondroid and bone differentiation of the chest wall</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Alejandro A. Gru</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Daniel J. Santa Cruz</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-12-29T22:04:21.426318-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01855.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01855.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01855.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Lipomas are the most common subtype of benign soft tissue neoplasms and can occur anywhere in the body. Differentiation into a diversity of mesenchymal elements, such as blood vessels, fibrous tissue or muscle, is a frequent event. However, the presence of bone or cartilage in these tumors is extraordinarily rare with very few cases reported in the head and neck area. We report a case of an ‘osteochondrolipoma’ of the chest wall, in a young individual, providing a rationale in support of this as a possible and distinctive histologic subtype of lipomas, as well as discussion in the differential diagnosis of this lesion.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Gru AA, Santa Cruz, DJ. Osteochondrolipoma: a subcutaneous lipoma with chondroid and bone differentiation of the chest wall.</p></div>]]></content:encoded><description>Lipomas are the most common subtype of benign soft tissue neoplasms and can occur anywhere in the body. Differentiation into a diversity of mesenchymal elements, such as blood vessels, fibrous tissue or muscle, is a frequent event. However, the presence of bone or cartilage in these tumors is extraordinarily rare with very few cases reported in the head and neck area. We report a case of an ‘osteochondrolipoma’ of the chest wall, in a young individual, providing a rationale in support of this as a possible and distinctive histologic subtype of lipomas, as well as discussion in the differential diagnosis of this lesion.Gru AA, Santa Cruz, DJ. Osteochondrolipoma: a subcutaneous lipoma with chondroid and bone differentiation of the chest wall.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01854.x" xmlns="http://purl.org/rss/1.0/"><title>Prominent CD56 expression by damaged and regenerating muscle fibers in the skin</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01854.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Prominent CD56 expression by damaged and regenerating muscle fibers in the skin</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kristopher Mckay</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jennifer McNiff</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Antonio Subtil</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-12-29T22:04:13.683973-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01854.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01854.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01854.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Background:</b> Antibodies to CD56 label natural killer cells as well as tissues with neural and neuroendocrine differentiation. Despite its apparently limited distribution, other conditions may unexpectedly show strong CD56 expression.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods:</b> We report three cases to document another setting with strong expression of CD56 in the skin: damaged and/or regenerating muscle fibers. One case of cutaneous lupus erythematosus, one case of lymphomatoid granulomatosis, and one case of a dermal scar adjacent to cutaneous muscle fibers were evaluated with a panel of antibodies, including CD56.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results:</b> All cases showed histopathologic evidence of muscle fiber damage in the setting of lymphocytic infiltration or trauma. All cases showed prominent expression of CD56 by damaged and/or regenerating muscle fibers. The degree of CD56 expression was directly proportional to the proximity to the injury site and inversely proportional to fiber diameter.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions:</b> Even though CD56 is a useful marker for certain cytotoxic lymphomas and neural/neuroendocrine neoplasms, its expression is not limited to these conditions. Our cases highlight another unexpected example of strong CD56 expression in the skin: damaged and/or regenerating muscle fibers. The growing list of CD56-positive conditions suggests that this marker may not be as specific as initially assumed.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Mckay K, McNiff J, Subtil A. Prominent CD56 expression by damaged and regenerating muscle fibers in the skin.</p></div>]]></content:encoded><description>Background: Antibodies to CD56 label natural killer cells as well as tissues with neural and neuroendocrine differentiation. Despite its apparently limited distribution, other conditions may unexpectedly show strong CD56 expression.Methods: We report three cases to document another setting with strong expression of CD56 in the skin: damaged and/or regenerating muscle fibers. One case of cutaneous lupus erythematosus, one case of lymphomatoid granulomatosis, and one case of a dermal scar adjacent to cutaneous muscle fibers were evaluated with a panel of antibodies, including CD56.Results: All cases showed histopathologic evidence of muscle fiber damage in the setting of lymphocytic infiltration or trauma. All cases showed prominent expression of CD56 by damaged and/or regenerating muscle fibers. The degree of CD56 expression was directly proportional to the proximity to the injury site and inversely proportional to fiber diameter.Conclusions: Even though CD56 is a useful marker for certain cytotoxic lymphomas and neural/neuroendocrine neoplasms, its expression is not limited to these conditions. Our cases highlight another unexpected example of strong CD56 expression in the skin: damaged and/or regenerating muscle fibers. The growing list of CD56-positive conditions suggests that this marker may not be as specific as initially assumed.Mckay K, McNiff J, Subtil A. Prominent CD56 expression by damaged and regenerating muscle fibers in the skin.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01838.x" xmlns="http://purl.org/rss/1.0/"><title>Plaque-like cutaneous mucinosis after joint replacement</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01838.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Plaque-like cutaneous mucinosis after joint replacement</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Silvia Gómez-Bernal</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Inmaculada Ruiz-González</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sonsoles Delgado-Vicente</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Teresa  Alonso-Alonso</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Manuel Ángel Rodríguez-Prieto</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-12-15T02:24:21.999852-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01838.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01838.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01838.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01836.x" xmlns="http://purl.org/rss/1.0/"><title>Familial multiple pilomatrixomas as a presentation of attenuated adenomatosis polyposis coli</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01836.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Familial multiple pilomatrixomas as a presentation of attenuated adenomatosis polyposis coli</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Joshua Trufant</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Wayne Kurz</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Amylynne Frankel</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Viswanathan Muthusamy</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Wendy McKinnon</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Marc Greenblatt</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Alex Lazar</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Deborah Cook</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Marcus Bosenberg</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-12-12T08:48:43.662292-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01836.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01836.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01836.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Pilomatrixomas are benign follicular tumors that occur most commonly in children. Rare multiple or familial pilomatrixomas have been associated with myotonic dystrophy and other disorders. Although sporadic pilomatrixomas and hybrid cutaneous cysts with pilomatrixoma-like features have been observed in some kindreds with Gardner syndrome, an autosomal dominant form of familial adenomatous polyposis, no definitive association has been made with multiple or familial pilomatrixomas. Here we describe two siblings with multiple pilomatrixomas who were also found to have a family history of colonic adenocarcinoma. Genetic testing revealed a mutation in the 5′ portion of the adenomatous polyposis coli (<em>APC</em>) gene, in a region associated with an attenuated APC phenotype. These findings show that multiple pilomatrixomas may be the presenting symptom of patients with <em>APC</em> gene mutations.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Trufant J, Kurz W, Frankel A, Muthusamy V, McKinnon W, Greenblatt M, Lazar A, Cook D, Bosenberg M. Familial multiple pilomatrixomas as a presentation of attenuated adenomatosis polyposis coli.</p></div>]]></content:encoded><description>Pilomatrixomas are benign follicular tumors that occur most commonly in children. Rare multiple or familial pilomatrixomas have been associated with myotonic dystrophy and other disorders. Although sporadic pilomatrixomas and hybrid cutaneous cysts with pilomatrixoma-like features have been observed in some kindreds with Gardner syndrome, an autosomal dominant form of familial adenomatous polyposis, no definitive association has been made with multiple or familial pilomatrixomas. Here we describe two siblings with multiple pilomatrixomas who were also found to have a family history of colonic adenocarcinoma. Genetic testing revealed a mutation in the 5′ portion of the adenomatous polyposis coli (APC) gene, in a region associated with an attenuated APC phenotype. These findings show that multiple pilomatrixomas may be the presenting symptom of patients with APC gene mutations.Trufant J, Kurz W, Frankel A, Muthusamy V, McKinnon W, Greenblatt M, Lazar A, Cook D, Bosenberg M. Familial multiple pilomatrixomas as a presentation of attenuated adenomatosis polyposis coli.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01832.x" xmlns="http://purl.org/rss/1.0/"><title>Primary cutaneous mantle cell lymphoma with blastic features: report of a rare case with special reference to staging and effectiveness of chemotherapy</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01832.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Primary cutaneous mantle cell lymphoma with blastic features: report of a rare case with special reference to staging and effectiveness of chemotherapy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Douglas W. Lynch</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Rashmi Verma</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Eric Larson</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Michael C. Geis</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ali D. Jassim</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-11-29T06:34:03.708401-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01832.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01832.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01832.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>We describe a case of blastic primary cutaneous mantle cell lymphoma (MCL) in an 83-year-old male with a complex medical history. The patient presented to his primary care physician with a nodular erythematous skin eruption on his thighs. Histopathologic examination showed a diffuse lymphoid infiltrate of intermediate to large cells that involved the dermis and subcutis but spared the epidermis. Immunohistochemical staining showed expression of CD20, CD5 and cyclin-D1. The lymphoma cells were negative for CD10 and CD23. Fluorescence <em>in situ</em> hybridization (FISH) analysis revealed a characteristic translocation [t(11;14)(q13;q32)], which is diagnostic of MCL. Cutaneous involvement by MCL is typically secondary because of widespread disease, and primary cutaneous MCL can only be diagnosed in the absence of extracutaneous involvement. Primary cutaneous MCL is extremely rare and requires proper clinical staging. In this case, clinical staging revealed no evidence of bone marrow or peripheral blood involvement, and positron emission tomography (PET) scan revealed weak, abnormal uptake only in a few cervical lymph nodes. Because of the lack of disseminated involvement, we favor the lesion to be a primary cutaneous MCL.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Lynch DW, Verma R, Larson E, Geis MC, Jassim AD. Primary cutaneous mantle cell lymphoma with blastic features: report of a rare case with special reference to staging and effectiveness of chemotherapy.</p></div>]]></content:encoded><description>We describe a case of blastic primary cutaneous mantle cell lymphoma (MCL) in an 83-year-old male with a complex medical history. The patient presented to his primary care physician with a nodular erythematous skin eruption on his thighs. Histopathologic examination showed a diffuse lymphoid infiltrate of intermediate to large cells that involved the dermis and subcutis but spared the epidermis. Immunohistochemical staining showed expression of CD20, CD5 and cyclin-D1. The lymphoma cells were negative for CD10 and CD23. Fluorescence in situ hybridization (FISH) analysis revealed a characteristic translocation [t(11;14)(q13;q32)], which is diagnostic of MCL. Cutaneous involvement by MCL is typically secondary because of widespread disease, and primary cutaneous MCL can only be diagnosed in the absence of extracutaneous involvement. Primary cutaneous MCL is extremely rare and requires proper clinical staging. In this case, clinical staging revealed no evidence of bone marrow or peripheral blood involvement, and positron emission tomography (PET) scan revealed weak, abnormal uptake only in a few cervical lymph nodes. Because of the lack of disseminated involvement, we favor the lesion to be a primary cutaneous MCL.Lynch DW, Verma R, Larson E, Geis MC, Jassim AD. Primary cutaneous mantle cell lymphoma with blastic features: report of a rare case with special reference to staging and effectiveness of chemotherapy.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01823.x" xmlns="http://purl.org/rss/1.0/"><title>A cutaneous vascular neoplasm with hobnail microscopic morphology and unusual gross features</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01823.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A cutaneous vascular neoplasm with hobnail microscopic morphology and unusual gross features</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">David Lukas Wachter</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Abbas Agaimy</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-11-21T01:57:35.473933-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01823.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01823.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01823.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Vascular tumors are categorized into benign hemangiomas, frankly malignant angiosarcomas and tumors with intermediate biological behavior (hemangioendotheliomas). The latter group includes hemangioendotheliomas of the epithelioid, kaposiform, retiform and composite subtypes. Furthermore, a heterogeneous group of both benign and intermediate vascular tumors exhibits a peculiar hobnail cell morphology. This heterogeneous group encompasses hobnail hemangioma, retiform hemangioendothelioma, papillary intralymphatic angioendothelioma and a subset of angiosarcoma. We herein present a case of a cutaneous vascular neoplasm with hobnail morphology and unusual gross features.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Wachter DL, Agaimy A. A cutaneous vascular neoplasm with hobnail microscopic morphology and unusual gross features.</p></div>]]></content:encoded><description>Vascular tumors are categorized into benign hemangiomas, frankly malignant angiosarcomas and tumors with intermediate biological behavior (hemangioendotheliomas). The latter group includes hemangioendotheliomas of the epithelioid, kaposiform, retiform and composite subtypes. Furthermore, a heterogeneous group of both benign and intermediate vascular tumors exhibits a peculiar hobnail cell morphology. This heterogeneous group encompasses hobnail hemangioma, retiform hemangioendothelioma, papillary intralymphatic angioendothelioma and a subset of angiosarcoma. We herein present a case of a cutaneous vascular neoplasm with hobnail morphology and unusual gross features.Wachter DL, Agaimy A. A cutaneous vascular neoplasm with hobnail microscopic morphology and unusual gross features.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01813.x" xmlns="http://purl.org/rss/1.0/"><title>Brooke-Spiegler syndrome: report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01813.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Brooke-Spiegler syndrome: report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Giovanni Ponti</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sabina Nasti</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lorena Losi</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lorenza Pastorino</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Annamaria Pollio</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Luisa Benassi</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Stefania Giudice</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Giorgia Bertazzoni</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Eugenia Veratti</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Paola Azzoni</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Giovanna Bianchi Scarrà</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Stefania Seidenari</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-11-12T02:25:53.610049-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01813.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01813.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01813.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Brooke-Spiegler syndrome represents an autosomal dominant disease characterized by the occurrence of multiple cylindromas, trichoepitheliomas and (sporadically) spiroadenomas. Patients with Brooke-Spiegler syndrome are also at risk of developing tumors of the major and minor salivary glands. Patients with Brooke-Spiegler syndrome have various mutations in the <em>CYLD</em> gene, a tumor-suppressor gene located on chromosome 16q. To date, 68 unique <em>CYLD</em> mutations have been identified. We describe two families with Brooke-Spiegler syndrome, one with familial cylindromatosis and one with multiple familial trichoepithelioma, which showed wide inter-family phenotypic variability. Analysis of germline mutations of the <em>CYLD</em> and <em>PTCH</em> genes was performed using peripheral blood. In addition, formalin-fixed paraffin-embedded tumor samples were analyzed for <em>PTCH</em> somatic mutations and cylindroma cell cultures were obtained directly from patients for further growth and analysis. Clinically, the major features of Brooke-Spiegler syndrome include the presence of heterogeneous skin tumors and wide inter- and intra-familial phenotypic variability. Histopathologically, both cylindromas and trichoepitheliomas were found in affected individuals. Mutations or loss of heterozygosity was not found in <em>CYLD</em> and <em>PTCH</em> genes. In <em>CYLD</em> and <em>PTCH</em> mutation-negative patients, other genes may be affected and further studies are needed to clarify whether these patients may be affected by <em>de novo</em> germline mutations.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Ponti G, Nasti S, Losi L, Pastorino L, Pollio A, Benassi L, Giudice S, Bertazzoni G, Veratti E, Azzoni P, Bianchi Scarrà G, Seidenari S. Brooke-Spiegler syndrome: report of two cases not associated with a mutation in the <em>CYLD</em> and <em>PTCH</em> tumor-suppressor genes.</p></div>]]></content:encoded><description>Brooke-Spiegler syndrome represents an autosomal dominant disease characterized by the occurrence of multiple cylindromas, trichoepitheliomas and (sporadically) spiroadenomas. Patients with Brooke-Spiegler syndrome are also at risk of developing tumors of the major and minor salivary glands. Patients with Brooke-Spiegler syndrome have various mutations in the CYLD gene, a tumor-suppressor gene located on chromosome 16q. To date, 68 unique CYLD mutations have been identified. We describe two families with Brooke-Spiegler syndrome, one with familial cylindromatosis and one with multiple familial trichoepithelioma, which showed wide inter-family phenotypic variability. Analysis of germline mutations of the CYLD and PTCH genes was performed using peripheral blood. In addition, formalin-fixed paraffin-embedded tumor samples were analyzed for PTCH somatic mutations and cylindroma cell cultures were obtained directly from patients for further growth and analysis. Clinically, the major features of Brooke-Spiegler syndrome include the presence of heterogeneous skin tumors and wide inter- and intra-familial phenotypic variability. Histopathologically, both cylindromas and trichoepitheliomas were found in affected individuals. Mutations or loss of heterozygosity was not found in CYLD and PTCH genes. In CYLD and PTCH mutation-negative patients, other genes may be affected and further studies are needed to clarify whether these patients may be affected by de novo germline mutations.Ponti G, Nasti S, Losi L, Pastorino L, Pollio A, Benassi L, Giudice S, Bertazzoni G, Veratti E, Azzoni P, Bianchi Scarrà G, Seidenari S. Brooke-Spiegler syndrome: report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01810.x" xmlns="http://purl.org/rss/1.0/"><title>Spiradenocarcinoma with low-grade basal cell adenocarcinoma pattern: report of a case with varied morphology and wild type TP53</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01810.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Spiradenocarcinoma with low-grade basal cell adenocarcinoma pattern: report of a case with varied morphology and wild type TP53</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Fredrik Petersson</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Min En Nga</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-11-12T02:25:47.258962-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01810.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01810.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01810.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>We present a patient with a 2-cm spiradenocarcinoma of the left arm resembling low-grade salivary gland basal cell adenocarcinoma. In addition to showing attributes of conventional spiradenoma, the benign component showed prominent areas of cystic change with focal apocrine differentiation, glands with and without mucinous differentiation, clear cell change and focal adenoid cystic carcinoma-like areas. The malignant component was composed of nodules of basaloid cells arranged in sheets with variable tendency to luminal differentiation. The nuclear atypia was low-grade, and the mitotic index was high in the malignant component (to 8/10 high power fields). Immunohistochemically, there was diffuse but variable positivity for cytokeratin 7 in both the benign and malignant components. Epithelial membrane antigen was focally positive, highlighting cells with ductal (luminal) differentiation. Expression of p63 was observed in 50 and 80% of the cells in the benign and malignant components, respectively. Calponin was negative. The proliferative index (MIB-1/Ki-67) was &lt;3% in the benign component and up to 10% in the malignant component. Although the malignant component displayed patchy areas with nuclear p53 immunoreactivity with variable intensity, no mutation in the <em>TP53</em> gene was identified.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Petersson F, Nga ME. Spiradenocarcinoma with low-grade basal cell adenocarcinoma pattern: report of a case with varied morphology and wild type <em>TP53</em>.</p></div>]]></content:encoded><description>We present a patient with a 2-cm spiradenocarcinoma of the left arm resembling low-grade salivary gland basal cell adenocarcinoma. In addition to showing attributes of conventional spiradenoma, the benign component showed prominent areas of cystic change with focal apocrine differentiation, glands with and without mucinous differentiation, clear cell change and focal adenoid cystic carcinoma-like areas. The malignant component was composed of nodules of basaloid cells arranged in sheets with variable tendency to luminal differentiation. The nuclear atypia was low-grade, and the mitotic index was high in the malignant component (to 8/10 high power fields). Immunohistochemically, there was diffuse but variable positivity for cytokeratin 7 in both the benign and malignant components. Epithelial membrane antigen was focally positive, highlighting cells with ductal (luminal) differentiation. Expression of p63 was observed in 50 and 80% of the cells in the benign and malignant components, respectively. Calponin was negative. The proliferative index (MIB-1/Ki-67) was &lt;3% in the benign component and up to 10% in the malignant component. Although the malignant component displayed patchy areas with nuclear p53 immunoreactivity with variable intensity, no mutation in the TP53 gene was identified.Petersson F, Nga ME. Spiradenocarcinoma with low-grade basal cell adenocarcinoma pattern: report of a case with varied morphology and wild type TP53.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01806.x" xmlns="http://purl.org/rss/1.0/"><title>Metastatic chondrosarcoma – current aspects of a rare event in dermatopathology</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01806.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Metastatic chondrosarcoma – current aspects of a rare event in dermatopathology</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Hedwig Stanisz</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Claudia Pföhler</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Konstantinos Anagnostakos</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Dieter Kohn</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Thomas Vogt</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Cornelia S.L. Müller</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-11-03T04:33:31.34025-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01806.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01806.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01806.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01792.x" xmlns="http://purl.org/rss/1.0/"><title>A case of cutaneous Scedosporium infection in an immunocompromised patient</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01792.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A case of cutaneous Scedosporium infection in an immunocompromised patient</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Melody K. Harrison</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kim H. Hiatt</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Bruce R. Smoller</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Wang L. Cheung</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-10-28T01:50:21.536063-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01792.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01792.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01792.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><em>Scedosporium apiospermum</em>, the asexual stage of <em>Pseudoallescheria boydii</em>, is a fungus ubiquitous in soil as well as organically polluted areas, where nitrogen-containing compounds are abundant. It is an emerging opportunistic pathogen that can range from cutaneous to disseminated infection and can be fatal within months of diagnosis. Here we present a case of disseminated <em>S. apiospermum</em> infection with cutaneous manifestations in a 59-year-old woman with myelodysplastic syndrome, in remission from chronic lymphocytic leukemia, presented with pneumonia and deteriorating mental status. An X-ray computed tomography scan showed three non-contrast-enhancing hypodensities affecting the brain. Many erythematous, indurated skin lesions, measuring 3–5 mm in diameter, were noted on her chest, shoulders and arms. Biopsies were submitted for culture and histology. Histopathologic examination revealed superficial and deep perivascular and periadnexal inflammatory infiltrates of lymphocytes and neutrophils. Scattered collections of fungal organisms were noted near the eccrine glands. The periodic acid Schiff with diastase stain showed the presence of variable sized spores and hyphae with some acute angle branching. Both tissue and blood cultures were positive for a single <em>Scedosporium</em> species. Histologically, eccrine or peri-eccrine involvement by fungi may be an important finding for <em>Scedosporium</em> infection of the skin.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Harrison MK, Hiatt KH, Smoller BR, Cheung WL. A case of cutaneous <em>Scedosporium</em> infection in an immunocompromised patient.</p></div>]]></content:encoded><description>Scedosporium apiospermum, the asexual stage of Pseudoallescheria boydii, is a fungus ubiquitous in soil as well as organically polluted areas, where nitrogen-containing compounds are abundant. It is an emerging opportunistic pathogen that can range from cutaneous to disseminated infection and can be fatal within months of diagnosis. Here we present a case of disseminated S. apiospermum infection with cutaneous manifestations in a 59-year-old woman with myelodysplastic syndrome, in remission from chronic lymphocytic leukemia, presented with pneumonia and deteriorating mental status. An X-ray computed tomography scan showed three non-contrast-enhancing hypodensities affecting the brain. Many erythematous, indurated skin lesions, measuring 3–5 mm in diameter, were noted on her chest, shoulders and arms. Biopsies were submitted for culture and histology. Histopathologic examination revealed superficial and deep perivascular and periadnexal inflammatory infiltrates of lymphocytes and neutrophils. Scattered collections of fungal organisms were noted near the eccrine glands. The periodic acid Schiff with diastase stain showed the presence of variable sized spores and hyphae with some acute angle branching. Both tissue and blood cultures were positive for a single Scedosporium species. Histologically, eccrine or peri-eccrine involvement by fungi may be an important finding for Scedosporium infection of the skin.Harrison MK, Hiatt KH, Smoller BR, Cheung WL. A case of cutaneous Scedosporium infection in an immunocompromised patient.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01782.x" xmlns="http://purl.org/rss/1.0/"><title>Oral arteriovenous hemangioma in patient with hepatitis C</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01782.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Oral arteriovenous hemangioma in patient with hepatitis C</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Victor Angelo Martins Montalli</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Elizabeth Ferreira Martinez</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Luiz Alexandre Thomaz</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Cristiane Furuse</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Vera Cavalcanti de Araújo</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-09-07T07:18:22.58374-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01782.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01782.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01782.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01691.x" xmlns="http://purl.org/rss/1.0/"><title>Verruciform xanthoma: localized lymphedema (elephantiasis) is an essential pathogenic factor</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01691.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Verruciform xanthoma: localized lymphedema (elephantiasis) is an essential pathogenic factor</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Song Lu</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Angela Rohwedder</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Michael Murphy</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. Andrew Carlson</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-03-01T06:24:39.265878-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01691.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01691.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01691.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2008.01181.x" xmlns="http://purl.org/rss/1.0/"><title>Acantholytic dyskeratotic epidermal nevus with eccrine differentiation: a case report and review of literature</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2008.01181.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Acantholytic dyskeratotic epidermal nevus with eccrine differentiation: a case report and review of literature</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Holly C. Shaffer</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Robert Schosser</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Charles Phillips</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2009-03-17T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2008.01181.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2008.01181.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2008.01181.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Terminology regarding classification of benign lesions with prominent eccrine differentiation can be confusing as these lesions can have overlapping clinical and histologic characteristics. In this report, we examine a case and review of the literature to suggest that these entities may be better classified as a spectrum of benign lesions with overlapping features rather than distinct entities. We describe a case of an acantholytic dyskeratotic epidermal nevus with eccrine differentiation on the back of a 2-year-old patient. We then discuss the classic clinical and histologic presentations of eccrine nevi and epidermal nevi with eccrine differentiation as they relate to each other and to our case.</p></div>]]></content:encoded><description>Terminology regarding classification of benign lesions with prominent eccrine differentiation can be confusing as these lesions can have overlapping clinical and histologic characteristics. In this report, we examine a case and review of the literature to suggest that these entities may be better classified as a spectrum of benign lesions with overlapping features rather than distinct entities. We describe a case of an acantholytic dyskeratotic epidermal nevus with eccrine differentiation on the back of a 2-year-old patient. We then discuss the classic clinical and histologic presentations of eccrine nevi and epidermal nevi with eccrine differentiation as they relate to each other and to our case.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2008.01204.x" xmlns="http://purl.org/rss/1.0/"><title>Expressions of p53, cyclinD1 and histopathological features in basal cell carcinomas</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2008.01204.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Expressions of p53, cyclinD1 and histopathological features in basal cell carcinomas</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Resit D. Koseoglu</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Engin Sezer</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ahmet Eyibilen</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">İbrahim Aladag</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">İlker Etikan</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2009-01-27T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2008.01204.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2008.01204.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2008.01204.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Background: </b> We planned this study to analyze probable associations between p53, cyclinD1, Ki67 and histopathological features in basal cell carcinomas (BCC).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods: </b> Histological differentiation types, histological growth patterns and tissue responses were analyzed in 50 cases of BCC. In immunohistochemical analysis, p53, cyclinD1 and Ki67 antibodies were investigated. P53 expression was evaluated based on a cut-off value of 25% positivity. CyclinD1 expression was graded from 0 to 3+ according to the percentage of positive nuclear staining. The percentage of positively staining cells for Ki67 was recorded.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results: </b> The following significant correlations were detected. Solid infiltrative type differentiation was related to the infiltrative histological growth pattern. The rates of p53 positivity and severe fibrosis in the groups of mixed and infiltrative growth patterns were higher than others. Besides, p53-positive cases showed more severe fibrosis and had a higher mean value for Ki67 index. Epidermal p53 and cyclinD1 clones in normal epidermal areas adjacent to tumors were noticed in 42% and 52% of the cases, respectively.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions: </b> P53 expression seems to be related to Ki67 index and some histopathological features of BCC, such as infiltrative histological growth pattern and probably fibrosis.</p></div>]]></content:encoded><description>Background:  We planned this study to analyze probable associations between p53, cyclinD1, Ki67 and histopathological features in basal cell carcinomas (BCC).Methods:  Histological differentiation types, histological growth patterns and tissue responses were analyzed in 50 cases of BCC. In immunohistochemical analysis, p53, cyclinD1 and Ki67 antibodies were investigated. P53 expression was evaluated based on a cut-off value of 25% positivity. CyclinD1 expression was graded from 0 to 3+ according to the percentage of positive nuclear staining. The percentage of positively staining cells for Ki67 was recorded.Results:  The following significant correlations were detected. Solid infiltrative type differentiation was related to the infiltrative histological growth pattern. The rates of p53 positivity and severe fibrosis in the groups of mixed and infiltrative growth patterns were higher than others. Besides, p53-positive cases showed more severe fibrosis and had a higher mean value for Ki67 index. Epidermal p53 and cyclinD1 clones in normal epidermal areas adjacent to tumors were noticed in 42% and 52% of the cases, respectively.Conclusions:  P53 expression seems to be related to Ki67 index and some histopathological features of BCC, such as infiltrative histological growth pattern and probably fibrosis.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01865_1.x" xmlns="http://purl.org/rss/1.0/"><title>A Novel Form of Amyloid Deposited at the Site of Enfuvirtide Injection</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01865_1.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A Novel Form of Amyloid Deposited at the Site of Enfuvirtide Injection</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Agne Naujokas</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Claudia I. Vidal</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Steven E. Mercer</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Joanna Harp</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Paul J. Kurtin</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lindy P. Fox</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Michele M. Thompson</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2012.01865_1.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2012.01865_1.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01865_1.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">219</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">219</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01865_2.x" xmlns="http://purl.org/rss/1.0/"><title>A Novel Form of Amyloid Deposited at the Site of Enfuvirtide Injection</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01865_2.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A Novel Form of Amyloid Deposited at the Site of Enfuvirtide Injection</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Agne Naujokas</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Claudia I. Vidal</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Steven E. Mercer</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Joanna Harp</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Paul J. Kurtin</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lindy P. Fox</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Michele M. Thompson</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2012.01865_2.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2012.01865_2.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01865_2.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">220</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">221</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01864.x" xmlns="http://purl.org/rss/1.0/"><title>The mistakable and the unmistakable</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01864.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The mistakable and the unmistakable</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Timothy H. McCalmont</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2012.01864.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2012.01864.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01864.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">222</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">224</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01825.x" xmlns="http://purl.org/rss/1.0/"><title>Cytokeratin 10-negative nested pattern enables sure distinction of clonal seborrheic keratosis from pagetoid Bowen's disease</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01825.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Cytokeratin 10-negative nested pattern enables sure distinction of clonal seborrheic keratosis from pagetoid Bowen's disease</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Almut Böer-Auer</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Meriem Jones</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Olesya V. Lyasnichaya</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01825.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01825.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01825.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">225</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">233</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Background:</b> The histopathologic pattern of clonal seborrheic keratosis (SK) is quite similar to the nested pattern of pagetoid Bowen's disease [squamous cell carcinoma <em>in situ</em> (SCCIS)], and differentiation between the two can be challenging, especially when only small pieces are available for interpretation.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods:</b> Eleven examples of clonal SK and 13 examples of pagetoid SCCIS were examined histopathologically (tabulating necrotic keratinocytes, suprabasal mitoses, infiltrate, parakeratosis housing plump nuclei, crowding of nuclei) and immunohistochemically (using Ki-67, bcl-2, cytokeratin 7 and cytokeratin 10). Sensitivity, specificity, p-values (Fisher's exact test, two-tailed) and positive/negative likelihood ratios (+LR/−LR) were calculated.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results:</b> Significant differences were seen with regard to crowding (p = 0.0009) and mitoses (p = 0.0006); however, only complete absence of necrotic keratinocytes or of crowding appeared to be diagnostically convincing for a diagnosis of clonal SK (−LR &lt; 0.01). Significant differences were also seen with bcl-2 (p = 0.0005) and cytokeratin 10 antibodies (p &lt; 0.00001). Both markers displayed a typical nested pattern in clonal SK, nests being bcl-2-positive and cytokeratin 10-negative. Cytokeratin 10-negative nests were the most convincing criterion for differentiation between clonal SK and pagetoid SCCIS (+LR &gt; 10, −LR &lt; 0.01).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions:</b> The most reliable marker to distinguish clonal SK from pagetoid SCCIS is cytokeratin 10 when it spares nests. Other criteria that assist in the differential diagnosis are bcl-2 expression, absence of crowding and of mitoses.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Böer-Auer A, Jones M, Lyasnichaya OV. Cytokeratin 10-negative nested pattern enables sure distinction of clonal seborrheic keratosis from pagetoid Bowen's disease.</p></div>]]></content:encoded><description>Background: The histopathologic pattern of clonal seborrheic keratosis (SK) is quite similar to the nested pattern of pagetoid Bowen's disease [squamous cell carcinoma in situ (SCCIS)], and differentiation between the two can be challenging, especially when only small pieces are available for interpretation.Methods: Eleven examples of clonal SK and 13 examples of pagetoid SCCIS were examined histopathologically (tabulating necrotic keratinocytes, suprabasal mitoses, infiltrate, parakeratosis housing plump nuclei, crowding of nuclei) and immunohistochemically (using Ki-67, bcl-2, cytokeratin 7 and cytokeratin 10). Sensitivity, specificity, p-values (Fisher's exact test, two-tailed) and positive/negative likelihood ratios (+LR/−LR) were calculated.Results: Significant differences were seen with regard to crowding (p = 0.0009) and mitoses (p = 0.0006); however, only complete absence of necrotic keratinocytes or of crowding appeared to be diagnostically convincing for a diagnosis of clonal SK (−LR &lt; 0.01). Significant differences were also seen with bcl-2 (p = 0.0005) and cytokeratin 10 antibodies (p &lt; 0.00001). Both markers displayed a typical nested pattern in clonal SK, nests being bcl-2-positive and cytokeratin 10-negative. Cytokeratin 10-negative nests were the most convincing criterion for differentiation between clonal SK and pagetoid SCCIS (+LR &gt; 10, −LR &lt; 0.01).Conclusions: The most reliable marker to distinguish clonal SK from pagetoid SCCIS is cytokeratin 10 when it spares nests. Other criteria that assist in the differential diagnosis are bcl-2 expression, absence of crowding and of mitoses.Böer-Auer A, Jones M, Lyasnichaya OV. Cytokeratin 10-negative nested pattern enables sure distinction of clonal seborrheic keratosis from pagetoid Bowen's disease.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01843.x" xmlns="http://purl.org/rss/1.0/"><title>FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01843.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Anthony P. Fernandez</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Yang Sun</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Raymond R.  Tubbs</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">John R. Goldblum</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Steven D. Billings</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01843.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01843.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01843.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">234</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">242</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Background:</b> Secondary angiosarcoma and benign but microscopically atypical vascular proliferations (herein referred to as atypical vascular lesion or AVL) are rare consequences of radiation therapy and/or chronic lymphedema most commonly seen in breast cancer patients. Differentiating angiosarcoma from AVL can be difficult due to overlapping clinical and microscopic features. Recently, amplification of <em>MYC</em> has been associated with 55–100% of secondary angiosarcomas but is reportedly absent in AVL. We examined a series of secondary angiosarcoma and AVL for <em>MYC</em> amplification by fluorescence <em>in situ</em> hybridization (FISH) and expression by immunohistochemistry to investigate the diagnostic utility for discriminating angiosarcoma from AVL.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods:</b> Cases of secondary angiosarcoma (n = 8) and AVL (n = 4) were retrieved from our archives and examined by FISH and immunohistochemistry.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results:</b> All angiosarcoma cases (8/8 = 100%) demonstrated high-level <em>MYC</em> amplification by FISH, whereas all AVLs (0/4 = 0%) were negative for <em>MYC</em> amplification. Additionally, all angiosarcoma cases (8/8 = 100%) demonstrated nuclear positivity for MYC, whereas all AVLs (0/4 = 0%) were negative.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion:</b> Amplification of <em>MYC</em> and nuclear expression of MYC is present in secondary angiosarcoma but not AVL. These ancillary tests can be useful to distinguish angiosarcoma from AVL in difficult cases.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Fernandez AP, Sun Y, Tubbs RR, Goldblum JR, Billings SD. FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations.</p></div>]]></content:encoded><description>Background: Secondary angiosarcoma and benign but microscopically atypical vascular proliferations (herein referred to as atypical vascular lesion or AVL) are rare consequences of radiation therapy and/or chronic lymphedema most commonly seen in breast cancer patients. Differentiating angiosarcoma from AVL can be difficult due to overlapping clinical and microscopic features. Recently, amplification of MYC has been associated with 55–100% of secondary angiosarcomas but is reportedly absent in AVL. We examined a series of secondary angiosarcoma and AVL for MYC amplification by fluorescence in situ hybridization (FISH) and expression by immunohistochemistry to investigate the diagnostic utility for discriminating angiosarcoma from AVL.Methods: Cases of secondary angiosarcoma (n = 8) and AVL (n = 4) were retrieved from our archives and examined by FISH and immunohistochemistry.Results: All angiosarcoma cases (8/8 = 100%) demonstrated high-level MYC amplification by FISH, whereas all AVLs (0/4 = 0%) were negative for MYC amplification. Additionally, all angiosarcoma cases (8/8 = 100%) demonstrated nuclear positivity for MYC, whereas all AVLs (0/4 = 0%) were negative.Conclusion: Amplification of MYC and nuclear expression of MYC is present in secondary angiosarcoma but not AVL. These ancillary tests can be useful to distinguish angiosarcoma from AVL in difficult cases.Fernandez AP, Sun Y, Tubbs RR, Goldblum JR, Billings SD. FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01834.x" xmlns="http://purl.org/rss/1.0/"><title>Use of proliferation rate, p53 staining and perforating elastic fibers in distinguishing keratoacanthoma from hypertrophic lichen planus: a pilot study</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01834.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Use of proliferation rate, p53 staining and perforating elastic fibers in distinguishing keratoacanthoma from hypertrophic lichen planus: a pilot study</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Anneli R. Bowen</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lindsay Burt</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kenneth Boucher</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Payam Tristani-Firouzi</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Scott R. Florell</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01834.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01834.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01834.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">243</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">250</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Background:</b> Distinguishing keratoacanthoma (KA) and hypertrophic lichen planus (LP) histopathologically can be difficult, and the challenge is compounded by the tendency of KA to arise in association with hypertrophic LP.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods:</b> In this pilot study, we compared 18 cases each of KA and hypertrophic LP for proliferation index (MIB-1), p53 staining and the presence of perforating elastic fibers (elastic Verhoeff-van Gieson) to determine the utility of these staining modalities in distinguishing KA from hypertrophic LP.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results:</b> Proliferation index in KA compared to hypertrophic LP is 88.2 (mean positive MIB-1 cells/×100 field), SD = 56.6 and 47.3, SD = 68.4, respectively. p53 staining in KA compared to hypertrophic LP is 251 (mean positive cells/×100 field), SD = 117 and 158, SD = 119, respectively. Fifteen of eighteen (83%) keratoacanthomata demonstrate perforating elastic fibers compared to 1/18 (6%) for hypertrophic LP.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion:</b> Proliferation index is not significantly different between KA and hypertrophic LP (p = 0.059). Expression of p53 is increased in KA over hypertrophic LP (p = 0.024). The presence of perforating elastic fibers in KA is significantly different from hypertrophic LP (p &lt; 0.0001) and suggests that elastic Verhoeff-van Gieson staining may be of practical benefit in distinguishing KA from hypertrophic LP in difficult cases.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Bowen AR, Burt L, Boucher K, Tristani-Firouzi P, Florell SR. Use of proliferation rate, p53 staining and perforating elastic fibers in the distinction of keratoacanthoma and hypertrophic lichen planus: a pilot study.</p></div>]]></content:encoded><description>Background: Distinguishing keratoacanthoma (KA) and hypertrophic lichen planus (LP) histopathologically can be difficult, and the challenge is compounded by the tendency of KA to arise in association with hypertrophic LP.Methods: In this pilot study, we compared 18 cases each of KA and hypertrophic LP for proliferation index (MIB-1), p53 staining and the presence of perforating elastic fibers (elastic Verhoeff-van Gieson) to determine the utility of these staining modalities in distinguishing KA from hypertrophic LP.Results: Proliferation index in KA compared to hypertrophic LP is 88.2 (mean positive MIB-1 cells/×100 field), SD = 56.6 and 47.3, SD = 68.4, respectively. p53 staining in KA compared to hypertrophic LP is 251 (mean positive cells/×100 field), SD = 117 and 158, SD = 119, respectively. Fifteen of eighteen (83%) keratoacanthomata demonstrate perforating elastic fibers compared to 1/18 (6%) for hypertrophic LP.Conclusion: Proliferation index is not significantly different between KA and hypertrophic LP (p = 0.059). Expression of p53 is increased in KA over hypertrophic LP (p = 0.024). The presence of perforating elastic fibers in KA is significantly different from hypertrophic LP (p &lt; 0.0001) and suggests that elastic Verhoeff-van Gieson staining may be of practical benefit in distinguishing KA from hypertrophic LP in difficult cases.Bowen AR, Burt L, Boucher K, Tristani-Firouzi P, Florell SR. Use of proliferation rate, p53 staining and perforating elastic fibers in the distinction of keratoacanthoma and hypertrophic lichen planus: a pilot study.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01844.x" xmlns="http://purl.org/rss/1.0/"><title>Cutaneous leishmaniasis mimicking inflammatory and neoplastic processes: a clinical, histopathological and molecular study of 57 cases</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01844.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Cutaneous leishmaniasis mimicking inflammatory and neoplastic processes: a clinical, histopathological and molecular study of 57 cases</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jad Saab</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Faysal Fedda</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ruba Khattab</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lamis Yahya</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Asif Loya</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mohamed Satti</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Abdul-Ghani Kibbi</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mohammad Adib Houreih</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Wasim Raslan</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Marwan El-Sabban</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ibrahim Khalifeh</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01844.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01844.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01844.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">251</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">262</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Background:</b> Cutaneous leishmaniasis displays considerable variation in its histopathological and clinical presentation. Clinically, it progresses from a papule into a painless ulcerated and crusted nodule/papule. Microscopically, it progresses from sheets of amastigote-filled histiocytes to granulomatous inflammation.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods:</b> The study was conducted on 145 skin biopsies from untreated patients with histopathological and/or clinical suspicion of cutaneous leishmaniasis in Lebanon, Syria and Saudi Arabia (1992–2010). The pre-biopsy clinical diagnosis and demographic data were collected. Biopsies were evaluated for the major microscopic pattern, and the parasitic index (PI) was also determined. Diagnosis was confirmed by polymerase chain reaction (PCR) followed by molecular sub-speciation.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results:</b> Of the 145 patients, 125 were confirmed as cutaneous leishmaniasis by PCR. Eighteen cases presented with a pre-biopsy clinical diagnosis other than cutaneous leishmaniasis that ranged from dermatitis to neoplasm. Of the 125 cases, 57 showed a major histopathological pattern other than cutaneous leishmaniasis. Identification of amastigotes was equivocal (PI ≤1) in 38 of the 57 cases. Of interest, all the 18 cases with a pre-biopsy clinical diagnosis other than cutaneous leishmaniasis also showed atypical histopathology for cutaneous leishmaniasis.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions:</b> The manifestations of cutaneous leishmaniasis are broad and may mimic other inflammatory and neoplastic diseases. Pathologists and dermatologists should be aware of such pitfalls and can utilize PCR to confirm the diagnosis of leishmaniasis.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Saab J, Fedda F, Khattab R, Yahya L, Loya A, Satti M, A-G Kibbi, Houreih MA, Raslan W, El-Sabban M, Khalifeh I. Cutaneous leishmaniasis mimicking inflammatory and neoplastic processes: a clinical, histopathological and molecular study of 57 cases.</p></div>]]></content:encoded><description>Background: Cutaneous leishmaniasis displays considerable variation in its histopathological and clinical presentation. Clinically, it progresses from a papule into a painless ulcerated and crusted nodule/papule. Microscopically, it progresses from sheets of amastigote-filled histiocytes to granulomatous inflammation.Methods: The study was conducted on 145 skin biopsies from untreated patients with histopathological and/or clinical suspicion of cutaneous leishmaniasis in Lebanon, Syria and Saudi Arabia (1992–2010). The pre-biopsy clinical diagnosis and demographic data were collected. Biopsies were evaluated for the major microscopic pattern, and the parasitic index (PI) was also determined. Diagnosis was confirmed by polymerase chain reaction (PCR) followed by molecular sub-speciation.Results: Of the 145 patients, 125 were confirmed as cutaneous leishmaniasis by PCR. Eighteen cases presented with a pre-biopsy clinical diagnosis other than cutaneous leishmaniasis that ranged from dermatitis to neoplasm. Of the 125 cases, 57 showed a major histopathological pattern other than cutaneous leishmaniasis. Identification of amastigotes was equivocal (PI ≤1) in 38 of the 57 cases. Of interest, all the 18 cases with a pre-biopsy clinical diagnosis other than cutaneous leishmaniasis also showed atypical histopathology for cutaneous leishmaniasis.Conclusions: The manifestations of cutaneous leishmaniasis are broad and may mimic other inflammatory and neoplastic diseases. Pathologists and dermatologists should be aware of such pitfalls and can utilize PCR to confirm the diagnosis of leishmaniasis.Saab J, Fedda F, Khattab R, Yahya L, Loya A, Satti M, A-G Kibbi, Houreih MA, Raslan W, El-Sabban M, Khalifeh I. Cutaneous leishmaniasis mimicking inflammatory and neoplastic processes: a clinical, histopathological and molecular study of 57 cases.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01812.x" xmlns="http://purl.org/rss/1.0/"><title>Primary cutaneous amyloidosis of the external ear: a clinicopathological and immunohistochemical study of 17 cases</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01812.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Primary cutaneous amyloidosis of the external ear: a clinicopathological and immunohistochemical study of 17 cases</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Scott F. Wenson</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Chad J. Jessup</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Matthew M. Johnson</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lisa M. Cohen</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mandana Mahmoodi</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01812.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01812.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01812.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">263</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">269</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Primary cutaneous amyloidosis includes several forms of localized amyloidosis characterized by superficial amyloid deposits occurring at or near the dermal–epidermal junction in the absence of systemic involvement. Primary cutaneous amyloidosis of the auricular concha and external ear represents a rarely described variant. There have been 27 cases reported in the English language literature, and herein we report 17 additional cases. This article demonstrates that the amyloid observed in this context is generally positive for Congo red, crystal violet and thioflavin T. It also expresses cytokeratin 34ßE12 via immunohistochemistry. Our immunohistochemical results and review of the literature suggest that the amyloid in amyloidosis of the external ear is the result of basal keratinocyte degeneration and does not signify deposition from a systemic or generalized process.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Wenson SF, Jessup CJ, Johnson MM, Cohen LM, Mahmoodi M. Primary cutaneous amyloidosis of the external ear: a clinicopathological and immunohistochemical study of 17 cases.</p></div>]]></content:encoded><description>Primary cutaneous amyloidosis includes several forms of localized amyloidosis characterized by superficial amyloid deposits occurring at or near the dermal–epidermal junction in the absence of systemic involvement. Primary cutaneous amyloidosis of the auricular concha and external ear represents a rarely described variant. There have been 27 cases reported in the English language literature, and herein we report 17 additional cases. This article demonstrates that the amyloid observed in this context is generally positive for Congo red, crystal violet and thioflavin T. It also expresses cytokeratin 34ßE12 via immunohistochemistry. Our immunohistochemical results and review of the literature suggest that the amyloid in amyloidosis of the external ear is the result of basal keratinocyte degeneration and does not signify deposition from a systemic or generalized process.Wenson SF, Jessup CJ, Johnson MM, Cohen LM, Mahmoodi M. Primary cutaneous amyloidosis of the external ear: a clinicopathological and immunohistochemical study of 17 cases.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01817.x" xmlns="http://purl.org/rss/1.0/"><title>Herpes simplex virus-induced plasmacytic atypia</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01817.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Herpes simplex virus-induced plasmacytic atypia</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Alan S. Boyd</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jeffrey P. Zwerner</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jami L. Miller</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01817.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01817.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01817.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">270</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">273</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>The clinical and histopathological features of cutaneous herpes simplex virus (HSV) infection have been well described. Genital herpetic infections are largely induced by HSV type 2, but 30% of cases can be caused by HSV type 1. Immunocompromised patients are known to exhibit atypical patterns of clinical presentation with variable lesion morphology and anatomic location. A subset of patients may show morphology such as nodules or verrucous lesions. Analogously, some biopsy specimens may show unusual microscopical features, such as a lack of keratinocyte cytopathology, lymphocyte infiltration or vasculopathic changes that are expected irrespective of the patient's immune status. We present the case of a patient carrying a previous diagnosis of pemphigus vulgaris, status posttreatment with methotrexate and prednisone, who developed a perineal ulcer exhibiting significant numbers of plasma cells, many of which were cytologically atypical. This morphology was suggestive of a hematopoietic malignancy. Immunoperoxidase staining for HSV decorated a focal collection of keratinocytes that lacked appreciable viral changes expected of HSV infection.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Boyd AS, Zwerner JP, Miller JL. Herpes simplex virus-induced plasmacytic atypia.</p></div>]]></content:encoded><description>The clinical and histopathological features of cutaneous herpes simplex virus (HSV) infection have been well described. Genital herpetic infections are largely induced by HSV type 2, but 30% of cases can be caused by HSV type 1. Immunocompromised patients are known to exhibit atypical patterns of clinical presentation with variable lesion morphology and anatomic location. A subset of patients may show morphology such as nodules or verrucous lesions. Analogously, some biopsy specimens may show unusual microscopical features, such as a lack of keratinocyte cytopathology, lymphocyte infiltration or vasculopathic changes that are expected irrespective of the patient's immune status. We present the case of a patient carrying a previous diagnosis of pemphigus vulgaris, status posttreatment with methotrexate and prednisone, who developed a perineal ulcer exhibiting significant numbers of plasma cells, many of which were cytologically atypical. This morphology was suggestive of a hematopoietic malignancy. Immunoperoxidase staining for HSV decorated a focal collection of keratinocytes that lacked appreciable viral changes expected of HSV infection.Boyd AS, Zwerner JP, Miller JL. Herpes simplex virus-induced plasmacytic atypia.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01814.x" xmlns="http://purl.org/rss/1.0/"><title>Human herpesvirus 8-associated lymphoma mimicking cutaneous anaplastic large T-cell lymphoma in a patient with human immunodeficiency virus infection</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01814.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Human herpesvirus 8-associated lymphoma mimicking cutaneous anaplastic large T-cell lymphoma in a patient with human immunodeficiency virus infection</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Meng-Fang Li</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Cheng-Hsiang Hsiao</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Yi-Lin Chen</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Wen-Ya Huang</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Yi-Hsuan Lee</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Hsien-Neng Huang</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Huang-Chun Lien</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01814.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01814.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01814.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">274</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">278</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Primary effusion lymphoma, a human herpesvirus 8 (HHV8)-associated lymphoma, is uncommon, and it is usually seen in human immunodeficiency virus (HIV)-infected patients. It presents as a body cavity-based lymphomatous effusion, but several cases of the so-called solid primary effusion lymphoma presenting as solid tumors without associated lymphomatous effusion have been reported. They have similar clinical, histopathological and immunophenotypical features. Most of them have a B-cell genotype. This suggests the solid variant may represent a clinicopathological spectrum of primary effusion lymphoma. We report a case of HHV8-associated lymphoma histopathologically and immunophenotypically mimicking cutaneous anaplastic large cell lymphoma. The patient was a 31-year-old HIV-seropositive man presenting with skin nodules over his right thigh. Biopsy of the nodules showed anaplastic large cells infiltrating the dermis. These malignant cells strongly expressed CD3, CD30 and CD43. Cutaneous anaplastic large T-cell lymphoma was initially diagnosed, but further tests, including immunoreactivity for HHV8 protein and clonal rearrangements of immunoglobulin genes, confirmed the diagnosis of HHV8-associated B-cell lymphoma with aberrant T-cell marker expression. This case provides an example of solid primary effusion lymphoma mimicking cutaneous anaplastic large T-cell lymphoma and highlights the importance of HHV8 immunohistochemistry and molecular tests in the diagnosis of HHV8-associated lymphoma with a cutaneous presentation.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Li M-F, Hsiao C-H, Chen Y-L, Huang W-Y, Lee Y-H, Huang H-N, Lien H-C. Human herpesvirus 8-associated lymphoma mimicking cutaneous anaplastic large T-cell lymphoma in a patient with human immunodeficiency virus infection.</p></div>]]></content:encoded><description>Primary effusion lymphoma, a human herpesvirus 8 (HHV8)-associated lymphoma, is uncommon, and it is usually seen in human immunodeficiency virus (HIV)-infected patients. It presents as a body cavity-based lymphomatous effusion, but several cases of the so-called solid primary effusion lymphoma presenting as solid tumors without associated lymphomatous effusion have been reported. They have similar clinical, histopathological and immunophenotypical features. Most of them have a B-cell genotype. This suggests the solid variant may represent a clinicopathological spectrum of primary effusion lymphoma. We report a case of HHV8-associated lymphoma histopathologically and immunophenotypically mimicking cutaneous anaplastic large cell lymphoma. The patient was a 31-year-old HIV-seropositive man presenting with skin nodules over his right thigh. Biopsy of the nodules showed anaplastic large cells infiltrating the dermis. These malignant cells strongly expressed CD3, CD30 and CD43. Cutaneous anaplastic large T-cell lymphoma was initially diagnosed, but further tests, including immunoreactivity for HHV8 protein and clonal rearrangements of immunoglobulin genes, confirmed the diagnosis of HHV8-associated B-cell lymphoma with aberrant T-cell marker expression. This case provides an example of solid primary effusion lymphoma mimicking cutaneous anaplastic large T-cell lymphoma and highlights the importance of HHV8 immunohistochemistry and molecular tests in the diagnosis of HHV8-associated lymphoma with a cutaneous presentation.Li M-F, Hsiao C-H, Chen Y-L, Huang W-Y, Lee Y-H, Huang H-N, Lien H-C. Human herpesvirus 8-associated lymphoma mimicking cutaneous anaplastic large T-cell lymphoma in a patient with human immunodeficiency virus infection.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01807.x" xmlns="http://purl.org/rss/1.0/"><title>Cutaneous myoepithelioma arising within hidradenoma of the scalp</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01807.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Cutaneous myoepithelioma arising within hidradenoma of the scalp</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kiran Jakate</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kevin Wong</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jane Sirbovan</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Wedad Hanna</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01807.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01807.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01807.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">279</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">285</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>A 62-year-old man presented with a 2-year history of a 2-cm cystic mass involving his occiput. There had been recent enlargement, and the clinical impression was that of a pilar cyst. Histopathological sections showed a partially dermal solid and cystic proliferation. The tumor contained areas of glandular differentiation with cuboidal to columnar cells lining luminal and cystic spaces. A concurrent spindle cell proliferation was seen interspersed between glands and also formed broad, cellular sheets of cells. The stroma was sclerotic and without chondroid or myxoid elements. Immunohistochemistry showed that the spindled cells expressed S100 protein, cytokeratin and smooth muscle myosin. The immunohistochemical profile and the relationship with ductal elements supported myoepithelial differentiation. The proliferation warranted the diagnosis of myoepithelioma arising from a hidradenoma, which to our knowledge has not been previously described. In addition to discussing this case, we provide a brief review of epithelial–myoepithelial neoplasms encountered in the skin.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Jakate K, Wong K, Sirbovan J, Hanna W. Cutaneous myoepithelioma arising within hidradenoma of the scalp.</p></div>]]></content:encoded><description>A 62-year-old man presented with a 2-year history of a 2-cm cystic mass involving his occiput. There had been recent enlargement, and the clinical impression was that of a pilar cyst. Histopathological sections showed a partially dermal solid and cystic proliferation. The tumor contained areas of glandular differentiation with cuboidal to columnar cells lining luminal and cystic spaces. A concurrent spindle cell proliferation was seen interspersed between glands and also formed broad, cellular sheets of cells. The stroma was sclerotic and without chondroid or myxoid elements. Immunohistochemistry showed that the spindled cells expressed S100 protein, cytokeratin and smooth muscle myosin. The immunohistochemical profile and the relationship with ductal elements supported myoepithelial differentiation. The proliferation warranted the diagnosis of myoepithelioma arising from a hidradenoma, which to our knowledge has not been previously described. In addition to discussing this case, we provide a brief review of epithelial–myoepithelial neoplasms encountered in the skin.Jakate K, Wong K, Sirbovan J, Hanna W. Cutaneous myoepithelioma arising within hidradenoma of the scalp.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01799.x" xmlns="http://purl.org/rss/1.0/"><title>The rare occurrence of three subungual melanomas in one patient</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01799.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The rare occurrence of three subungual melanomas in one patient</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Yeqiang Liu</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lei Wang</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01799.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01799.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01799.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">286</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">288</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Subungual melanoma commonly presents with solitary longitudinal melanonychia. Herein, we report the case of a patient with subungual melanoma who developed involvement of three digits by three independent primary melanomas. A 98-year-old male patient presented with a two-year history of longitudinal melanonychia on three different fingernails. Histopathologically, all three lesions were proved to be melanoma. To our knowledge, this is the first reported case in which three subungual melanomas developed in one patient. Our case indicates that that not all examples of multiple longitudinal melanonychia represent benign lesions.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Liu Y, Wang L. The rare occurrence of three subungual melanomas in one patient.</p></div>]]></content:encoded><description>Subungual melanoma commonly presents with solitary longitudinal melanonychia. Herein, we report the case of a patient with subungual melanoma who developed involvement of three digits by three independent primary melanomas. A 98-year-old male patient presented with a two-year history of longitudinal melanonychia on three different fingernails. Histopathologically, all three lesions were proved to be melanoma. To our knowledge, this is the first reported case in which three subungual melanomas developed in one patient. Our case indicates that that not all examples of multiple longitudinal melanonychia represent benign lesions.Liu Y, Wang L. The rare occurrence of three subungual melanomas in one patient.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01795.x" xmlns="http://purl.org/rss/1.0/"><title>Etanercept-induced cutaneous and pulmonary sarcoid-like granulomas resolving with adalimumab</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01795.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Etanercept-induced cutaneous and pulmonary sarcoid-like granulomas resolving with adalimumab</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ariel M. Burns</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Peter J. Green</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sylvia Pasternak</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01795.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01795.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01795.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">289</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">293</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>A 59-year-old female with rheumatoid arthritis on etanercept therapy presented with a 7-cm-large subcutaneous forearm mass. Multiple smaller nodules subsequently developed on the upper and lower extremities. Except for a new cough, the patient was systemically well. Biopsy of the mass showed sarcoidal type granulomatous inflammation with nodular aggregations of non-necrotizing epithelioid histiocytes in the subcutis. A chest computed tomography (CT) scan showed mediastinal adenopathy consistent with pulmonary sarcoidosis. Etanercept was discontinued, and the patient was started on adalimumab for rheumatoid arthritis control. The cutaneous nodules fully resolved in 6 months with no additional treatment. A 4-month follow-up CT scan showed significant regression of mediastinal adenopathy. The patient has since been maintained on adalimumab therapy for 2 years with no recurrence of sarcoid-like manifestations. Biologic response modifiers targeting tumor necrosis factor alpha (TNFα) are effective treatments of chronic inflammatory conditions such as rheumatoid arthritis and psoriasis. TNFα represents a major cytokine in granuloma formation, and TNFα inhibitors are sometimes efficacious in the treatment of sarcoidosis. Paradoxically, there is a small volume of literature implicating TNFα inhibitors in the development of sarcoid-like disease. We present this case to promote the recognition of TNFα inhibitor-induced sarcoidosis and to illustrate the wide clinicopathologic differential of sarcoidal type granulomas.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Burns AM, Green PJ, Pasternak S. Etanercept-induced cutaneous and pulmonary sarcoid-like granulomas resolving with adalimumab.</p></div>]]></content:encoded><description>A 59-year-old female with rheumatoid arthritis on etanercept therapy presented with a 7-cm-large subcutaneous forearm mass. Multiple smaller nodules subsequently developed on the upper and lower extremities. Except for a new cough, the patient was systemically well. Biopsy of the mass showed sarcoidal type granulomatous inflammation with nodular aggregations of non-necrotizing epithelioid histiocytes in the subcutis. A chest computed tomography (CT) scan showed mediastinal adenopathy consistent with pulmonary sarcoidosis. Etanercept was discontinued, and the patient was started on adalimumab for rheumatoid arthritis control. The cutaneous nodules fully resolved in 6 months with no additional treatment. A 4-month follow-up CT scan showed significant regression of mediastinal adenopathy. The patient has since been maintained on adalimumab therapy for 2 years with no recurrence of sarcoid-like manifestations. Biologic response modifiers targeting tumor necrosis factor alpha (TNFα) are effective treatments of chronic inflammatory conditions such as rheumatoid arthritis and psoriasis. TNFα represents a major cytokine in granuloma formation, and TNFα inhibitors are sometimes efficacious in the treatment of sarcoidosis. Paradoxically, there is a small volume of literature implicating TNFα inhibitors in the development of sarcoid-like disease. We present this case to promote the recognition of TNFα inhibitor-induced sarcoidosis and to illustrate the wide clinicopathologic differential of sarcoidal type granulomas.Burns AM, Green PJ, Pasternak S. Etanercept-induced cutaneous and pulmonary sarcoid-like granulomas resolving with adalimumab.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01811.x" xmlns="http://purl.org/rss/1.0/"><title>Actinic granuloma occurring in an unusual association with cutaneous B-cell chronic lymphocytic leukemia</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01811.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Actinic granuloma occurring in an unusual association with cutaneous B-cell chronic lymphocytic leukemia</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Julia A. Kauffman</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Doina Ivan</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jonathan E. Cutlan</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sharon R. Hymes</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01811.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01811.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01811.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">294</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">297</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Granulomatous cutaneous reactions are well described in association with T-cell non-Hodgkin lymphoma and Hodgkin lymphoma, but are rarely seen in association with B-cell non-Hodgkin lymphoma or leukemia. We report a case of a 65-year-old woman with B-cell chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who presented with multiple, tender, firm pink papules on the face, upper trunk and upper extremities 6 years after diagnosis of CLL. Biopsy revealed both palisading granulomatous dermatitis consistent with actinic granuloma and a dense perivascular lymphocytic infiltrate consistent with the patient's known history of leukemia. This is an unusual manifestation of cutaneous B-cell CLL that is rarely seen.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Kauffman JA, Ivan DS, Cutlan JE, Hymes SR. Actinic granuloma occurring in an unusual association with cutaneous B-cell chronic lymphocytic leukemia.</p></div>]]></content:encoded><description>Granulomatous cutaneous reactions are well described in association with T-cell non-Hodgkin lymphoma and Hodgkin lymphoma, but are rarely seen in association with B-cell non-Hodgkin lymphoma or leukemia. We report a case of a 65-year-old woman with B-cell chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who presented with multiple, tender, firm pink papules on the face, upper trunk and upper extremities 6 years after diagnosis of CLL. Biopsy revealed both palisading granulomatous dermatitis consistent with actinic granuloma and a dense perivascular lymphocytic infiltrate consistent with the patient's known history of leukemia. This is an unusual manifestation of cutaneous B-cell CLL that is rarely seen.Kauffman JA, Ivan DS, Cutlan JE, Hymes SR. Actinic granuloma occurring in an unusual association with cutaneous B-cell chronic lymphocytic leukemia.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01827.x" xmlns="http://purl.org/rss/1.0/"><title>Folliculotropic metastatic melanoma: a distinct variant of metastatic melanoma</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01827.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Folliculotropic metastatic melanoma: a distinct variant of metastatic melanoma</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mitsuaki Ishida</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Hidetoshi Okabe</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01827.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01827.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01827.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">298</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">299</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01818.x" xmlns="http://purl.org/rss/1.0/"><title>Comment regarding the histopathology of terra firma-forme dermatosis</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01818.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Comment regarding the histopathology of terra firma-forme dermatosis</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">David R. Berk</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Misha M. Mutizwa</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01818.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01818.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01818.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">300</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">301</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01826.x" xmlns="http://purl.org/rss/1.0/"><title>The histopathology of terra firma-forme dermatosis: author's response</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01826.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The histopathology of terra firma-forme dermatosis: author's response</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Scott R. Dalton</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nektarios Lountzis</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Howard Pride</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01826.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01826.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01826.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">302</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">303</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01828.x" xmlns="http://purl.org/rss/1.0/"><title>Cutaneous dirofilariasis resulting in orchiectomy</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01828.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Cutaneous dirofilariasis resulting in orchiectomy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Alessandro D'Amuri</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Silvano Antonio Senatore</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Tiberio Giuseppe Carlà</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Federica Floccari</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Erminia Villani</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Pietro Leocata</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Giuliana Crisman</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01828.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01828.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01828.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">304</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">305</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01839.x" xmlns="http://purl.org/rss/1.0/"><title>The ‘Tyler technique’ for alopecia biopsies</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01839.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The ‘Tyler technique’ for alopecia biopsies</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Dirk Elston</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01839.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01839.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01839.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">306</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">306</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01840.x" xmlns="http://purl.org/rss/1.0/"><title>A comment regarding ‘follicular Swiss cheese’ in the diagnosis of alopecia areata</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01840.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A comment regarding ‘follicular Swiss cheese’ in the diagnosis of alopecia areata</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Alfredo Rebora</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2011.01840.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2011.01840.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2011.01840.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">307</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">308</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01875.x" xmlns="http://purl.org/rss/1.0/"><title>Dermatopathology calendar</title><link>http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01875.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Dermatopathology calendar</dc:title><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0560.2012.01875.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0560.2012.01875.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0560.2012.01875.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">309</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">309</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item></rdf:RDF>
